Western blot analysis
Total cell lysates were prepared and analyzed by SDS-PAGE as previously described 1 .
Tumor cells were washed twice with PBS and lysed with ice-cold RIPA buffer (20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 150 mM NaCl, 1% NP-40 and 1% SDS) containing one protease inhibitor tablet (cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail, Roche;
Mannheim, Germany). The tumor cells were harvested using a cell scraper and collected in an Eppendorf tube for 20 min at 4°C. The sample was centrifuged for 10 min at 13000 RPM at 4°C, and the supernatant was transferred to an Eppendorf tube. The total protein concentrations in the cell lysates were quantitatively assessed using the Bio-Rad Bradford assay (Mississauga, ON). Immunodetection was performed using an HRP-based SuperSignal Chemiluminescent Substrate (Pierce, Rockford, IL, USA). For quantification, the bands were measured using an AlphaImager 2200 system (Alpha Innotech, San Leandro, CA, USA) and normalized to the band density of β-actin. Argininosuccinate synthetase 1 (ASS1) expression was quantified and expressed as the ASS1 to β-actin ratio. These experiments were repeated using three independent batches of cell clones or cell lysates. The quantitative data are presented as values relative to those in the control cells. After incubation for 1 h, the absorbance at 490 nm was recorded using an ELISA plate reader.
Cell proliferation assay
To evaluate cell growth after ASS1 inhibition, α-methyl-DL-aspartic acid (MDLA;
Sigma-Aldrich, St. Louis, MO, USA) was added at a final concentration of 0 (PBS control), 0.5, 1, 5, or 10 mM for each group 2 .
Cell cycle analysis by flow cytometry
Tumor cells were analyzed for changes in cell cycle status via propidium iodide analysis as previously described 1 . Tumor cells (1×10 6 cells/well) were cultured in 6-well plates for 48 h.
Analysis was performed using a FACScan instrument (BD Biosciences, San Jose, CA, USA).
Experimental metastatic model of gastric carcinoma
The metastatic abilities of MKN45 and 3IB2 cell clones in vivo were evaluated using a hepatic metastasis model, in which 1 × 10 6 tumor cells in 0.05 mL of PBS were intrasplenically injected as previously described 1 . Fourteen days after MKN45 cell clone injection, the NOD/SCID mice were sacrificed, and liver metastases were examined macroscopically and histologically. Eleven days after 3IB2 cell clone injection, the ICR mice were sacrificed, and liver metastases were examined macroscopically and histologically.
Formalin-fixed paraffin-embedded sections of the liver and spleen were used for hematoxylin and eosin (H&E) staining. Each animal experiment was performed at least twice.
Ectopic ASS expression
Myc-DDK-tagged ASS1 (RC223189) was purchased from OriGene Technologies Inc.
(Rockville, MD). Human ASS1 cDNA was cloned into pCMV6 to produce ASS1 pCMV6.
AGS cells were transfected with an empty vector or ASS1 pCMV6 using the transfection reagent Lipofectamine 2000. The stable transfectants were selected using G418 (neomycin sulfate, 300 μg/mL). After limiting dilution analysis, cell clones were selected and maintained for further studies using G418. We established vector control (VC) and ASS1-overexpressing (ASS1-myc) clones. The cell lines were maintained in complete medium containing G418. To monitor the efficacy of ASS1 overexpression, the expression of this protein in the stable transfectants was analyzed by Western blotting.
Cell migration assay
Cell migration was evaluated by culturing 3IB2 cell clones in modified Boyden chambers (NeuroProbe, Inc., Gaithersburg, MD, USA) for 8 h as previously described 1 . To determine cell migration, 2.5 × 10 4 cells in serum-free medium were added to the upper chamber, and either 10% FCS-supplemented or serum-free medium was added to the bottom chamber as the chemoattractant. The stained cells were counted in 6 randomly selected fields using a microscope at 100x magnification. Each experiment was performed in triplicate and was repeated three times.
Supplementary Figure S1 . ( The results were obtained from three independent experiments. LV: lentivirus; P: parental cells; VC: vector control; RNAi-1 and RNAi-2: ASS1-specific shRNAs 1 and 2. NS, not significant, *P < 0.05, **P < 0.001, ***P < 0.0001. Figure S2 . Cell lysates were immunoblotted using anti-ASS1, anti-STAT3
Supplementary
and anti-β-actin antibodies. These cropped blots are shown in Fig. 1a, Fig. 1c, Fig. 4a , Fig. 4b and All data were obtained from three independent experiments. P: parental cells; VC: vector control; ASS1-myc: ASS1-and myc-overexpressing. NS, not significant, *P < 0.05, **P < 0.001, ***P < 0.0001. significant, ***P < 0.0001.

